相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The clinical and biological characteristics of NUP98-KDM5A pediatric acute myeloid leukemia
Sanne Noort et al.
HAEMATOLOGICA (2021)
Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children
Christopher E. Dandoy et al.
HAEMATOLOGICA (2021)
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
Erica Brivio et al.
BLOOD (2021)
Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia
F. Saglio et al.
BONE MARROW TRANSPLANTATION (2021)
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation
Muna Qayed et al.
BLOOD (2021)
Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens
A. B. Versluys et al.
BONE MARROW TRANSPLANTATION (2021)
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Benjamin Watkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Christina Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
Jakob R. Passweg et al.
BONE MARROW TRANSPLANTATION (2021)
Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of αβ T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia
Maria Dunaikina et al.
BONE MARROW TRANSPLANTATION (2021)
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial
Patrick A. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial
Franco Locatelli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Nico Gagelmann et al.
FRONTIERS IN IMMUNOLOGY (2021)
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Nirali N. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
Naval Daver et al.
LEUKEMIA (2021)
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A. Pollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Base-edited CAR T cells for combinational therapy against T cell malignancies
Christos Georgiadis et al.
LEUKEMIA (2021)
Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia
Annalisa Ruggeri et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Pediatric relapsed acute myeloid leukemia: a systematic review
Anne E. Hoffman et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
Stefan O. Ciurea et al.
BONE MARROW TRANSPLANTATION (2020)
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria et al.
HAEMATOLOGICA (2020)
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
Yishai Ofran et al.
LEUKEMIA (2020)
Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)
Antonio Perez-Martinez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
Ewelina Mamcarz et al.
BONE MARROW TRANSPLANTATION (2020)
Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial
Martin G. Sauer et al.
LEUKEMIA (2020)
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study
Sandra Cohen et al.
LANCET HAEMATOLOGY (2020)
Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study
Francesco Saglio et al.
BONE MARROW TRANSPLANTATION (2020)
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children
Theodor Uden et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Comparison of melphalan- And busulfan-based myeloablative conditioning in children undergoing allogeneic transplantation for acute myeloid leukemia or myelodysplasia
Benjamin Oshrine et al.
PEDIATRIC TRANSPLANTATION (2020)
Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group
Stefano Giardino et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
Krzysztof Kalwak et al.
BONE MARROW TRANSPLANTATION (2020)
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study
Andre Manfred Willasch et al.
BONE MARROW TRANSPLANTATION (2020)
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia
Pietro Merli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cord blood transplantation for acute leukemia
Mattia Algeri et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
Franco Locatelli et al.
BLOOD CANCER JOURNAL (2020)
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
Heather J. Symons et al.
BLOOD ADVANCES (2020)
CAR T cells vs allogeneic HSCT for poor-risk ALL
Caroline Diorio et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
CAR T cells for other pediatric non-B-cell hematologic malignancies
Adam J. Lamble et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group
Martina Pigazzi et al.
BLOOD (2020)
AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation?
Shahrzad Bakhtiar et al.
BONE MARROW TRANSPLANTATION (2019)
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani et al.
LEUKEMIA (2019)
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
Diego Sanchez-Martinez et al.
BLOOD (2019)
Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation
Brice Mouttet et al.
HAEMATOLOGICA (2019)
Genomic subtyping and therapeutic targeting of acute erythroleukemia
Ilaria Iacobucci et al.
NATURE GENETICS (2019)
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group
Jennifer L. McNeer et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
Roya Rafiee et al.
BLOOD CANCER JOURNAL (2019)
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
Fotini Vogiatzi et al.
BLOOD (2019)
Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease
Laura Balligand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Comparative Analysis of Alpha-Beta T-Cell and B-Cell Depleted (abTCD) HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT) Versus Abtcd Haplo-HSCT with T-Cell Add-Back of Rivogenlecleucel Cell [Donor T Cells Transduced with the Inducible Caspase 9 (iC9) Gene Safety Switch] in Children with High-Risk Acute Leukemia (AL) in Remission
Annalisa Ruggeri et al.
BLOOD (2019)
Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide
Mitchell E. Horwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia
Ashleigh Kussman et al.
PEDIATRIC BLOOD & CANCER (2019)
Opportunities for immunotherapy in childhood acute myeloid leukemia
Adam J. Lamble et al.
BLOOD ADVANCES (2019)
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Peter Bader et al.
BLOOD ADVANCES (2019)
Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia
Trausti Oskarsson et al.
PEDIATRIC BLOOD & CANCER (2018)
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes
Jean-Hugues Dalle et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium
Eneida R. Nemecek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
David A. Jacobsohn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL
Anna Maria Testi et al.
BLOOD (2018)
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia
Federica Lovisa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Martin Stanulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
Mareike Rasche et al.
LEUKEMIA (2018)
An off-the-shelf fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
Matthew L. Cooper et al.
LEUKEMIA (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
Francesca Lorentino et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol et al.
BLOOD (2018)
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
Sanne Noort et al.
BLOOD (2018)
Unrelated donor vs HLA-haploidentical alpha/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia
Alice Bertaina et al.
BLOOD (2018)
Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia Patients Treated with Tisagenlecleucel
Michael A. Pulsipher et al.
BLOOD (2018)
Long Term Follow-up after SCRI-CAR19v1 Reveals Late Recurrences As Well As a Survival Advantage to Consolidation with HCT after CAR T Cell Induced Remission
Corinne Summers et al.
BLOOD (2018)
Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias
Franco Locatelli et al.
BLOOD (2018)
Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse
TaeHyung Kim et al.
BLOOD (2018)
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group
V. Bisio et al.
LEUKEMIA (2017)
NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis
S. Struski et al.
LEUKEMIA (2017)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Jatinder K. Lamba et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Genetic Basis of Acute Lymphoblastic Leukemia
Ilaria Iacobucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial
Franco Locatelli et al.
LANCET ONCOLOGY (2017)
Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
M. Rasche et al.
LEUKEMIA (2017)
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Jasmijn D. E. de Rooij et al.
NATURE GENETICS (2017)
Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation
Franco Locatelli et al.
ONCOTARGET (2017)
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders
Alice Bertaina et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor
A. Bertaina et al.
ONCOIMMUNOLOGY (2017)
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion
Franco Locatelli et al.
BLOOD (2017)
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes-Silva et al.
BLOOD (2017)
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Rebecca A. Gardner et al.
BLOOD (2017)
Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience
P. O'Hare et al.
BONE MARROW TRANSPLANTATION (2017)
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol
Barbara Buldini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation
Giovanna Lucchini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation
Eva Rettinger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock et al.
CLINICAL CANCER RESEARCH (2016)
Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation
Barbarella Lucarelli et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Role of Second Transplantation for Children With Acute Myeloid Leukemia Following Posttransplantation Relapse
Takashi Taga et al.
PEDIATRIC BLOOD & CANCER (2016)
Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency
Giuseppina Li Pira et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome
Gerard Michel et al.
BLOOD (2016)
Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO-AML 2004 study
Anne Tierens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
Eva Rettinger et al.
HAEMATOLOGICA (2016)
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Jessica A. Pollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia
Y. Zhou et al.
LEUKEMIA (2016)
Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Treatment-related adverse events associated with amodified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia
Weili Sun et al.
PEDIATRIC BLOOD & CANCER (2016)
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
Eva Rettinger et al.
HAEMATOLOGICA (2016)
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation
Hiroyuki Ishida et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies
Biljana Horn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies
Swati Naik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
Thomas Schroeder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies
Maksim Mamonkin et al.
BLOOD (2015)
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Michael A. Pulsipher et al.
BLOOD (2015)
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes
Irma Airoldi et al.
BLOOD (2015)
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
Jacques J. M. van Dongen et al.
BLOOD (2015)
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
M. A. Pulsipher et al.
BONE MARROW TRANSPLANTATION (2015)
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease
Luisa Strocchio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial
Paola Quarello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors-The ALL-SCT-BFM-2003 Trial
Christina Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
C. Eckert et al.
LEUKEMIA (2015)
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
Ute Fischer et al.
NATURE GENETICS (2015)
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation
Motohiro Kato et al.
PEDIATRIC BLOOD & CANCER (2015)
Sorafenib Treatment Following Hematopoietic Stem Cell Transplant in Pediatric FLT3/ITD Acute Myeloid Leukemia
Katherine Tarlock et al.
PEDIATRIC BLOOD & CANCER (2015)
Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia
Heidrun Boztug et al.
ANNALS OF HEMATOLOGY (2015)
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study
F. Locatelli et al.
BONE MARROW TRANSPLANTATION (2015)
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement
Martina Pigazzi et al.
HAEMATOLOGICA (2015)
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy
Mary Eapen et al.
BLOOD (2014)
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
Michael A. Pulsipher et al.
BLOOD (2014)
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
Lena Oevermann et al.
BLOOD (2014)
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene
Xiaoou Zhou et al.
BLOOD (2014)
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
Menachem Bitan et al.
BLOOD (2014)
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
Alice Bertaina et al.
BLOOD (2014)
Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI plus CY versus BU plus CY: a report from the Societete Francaise de Greffe de Moelle et de Therapie Cellulaire
E. de Berranger et al.
BONE MARROW TRANSPLANTATION (2014)
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?
Adriana Balduzzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Peter Lang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group
Katherine Tarlock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol
Virginie Gandemer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
A critical review of which children with acute myeloid leukaemia need stem cell procedures
Henrik Hasle
BRITISH JOURNAL OF HAEMATOLOGY (2014)
t(6;9)(p22; q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients
Julie Damgaard Sandahl et al.
HAEMATOLOGICA (2014)
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Alan S. Gamis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial
Ajay Vora et al.
LANCET ONCOLOGY (2014)
One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers
John E. Wagner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for AML With Down Syndrome
Hideki Muramatsu et al.
PEDIATRIC BLOOD & CANCER (2014)
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor and Melphalan (FALG with L-PAM) as a Reduced Toxicity Conditioning Regimen in Children with Acute Leukemia
Koji Kato et al.
PEDIATRIC BLOOD & CANCER (2014)
Transplantation Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia
James Tracey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group
Eva A. Coenen et al.
BLOOD (2013)
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype
Riccardo Masetti et al.
BLOOD (2013)
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
Andrea Pession et al.
BLOOD (2013)
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy
Marta Pratcorona et al.
BLOOD (2013)
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia
Norio Shiba et al.
GENES CHROMOSOMES & CANCER (2013)
Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry
Franca Fagioli et al.
HAEMATOLOGICA (2013)
Negative depletion of α/β+ T cells and of CD19+B lymphocytes: A novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation
Franco Locatelli et al.
IMMUNOLOGY LETTERS (2013)
Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials
Anthony V. Moorman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group
Nyla A. Heerema et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies
Franco Locatelli et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Outcome of Pediatric Patients With Acute Myeloid Leukemia (AML) and-5/5q-Abnormalities From Five Pediatric AML Treatment Protocols: A Report From the Children's Oncology Group
Donna L. Johnston et al.
PEDIATRIC BLOOD & CANCER (2013)
A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
Prakash Satwani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
Michael R. Loken et al.
BLOOD (2012)
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
Wing Leung et al.
BLOOD (2012)
How I treat relapsed childhood acute lymphoblastic leukemia
Franco Locatelli et al.
BLOOD (2012)
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Malek Faham et al.
BLOOD (2012)
Childhood acute myeloid leukaemia
Jeffrey E. Rubnitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
Tanja A. Gruber et al.
CANCER CELL (2012)
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
Hiroto Inaba et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
Salut Brunet et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis
A. Ruggeri et al.
LEUKEMIA (2012)
Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
Martin Schrappe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single Institution
Amy E. DeZern et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
Lorenzo Moretta et al.
BLOOD (2011)
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission
Giorgio Dini et al.
BLOOD (2011)
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
Wing Leung et al.
BLOOD (2011)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
Martin Schrappe et al.
BLOOD (2011)
Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis
Mary Eapen et al.
LANCET ONCOLOGY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann et al.
BLOOD (2010)
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors
Peter J. Shaw et al.
BLOOD (2010)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
Christine von Neuhoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
Christine J. Harrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
Catriona Parker et al.
LANCET (2010)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E. Rubnitz et al.
LANCET ONCOLOGY (2010)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Daniela Pende et al.
BLOOD (2009)
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A. Ho et al.
BLOOD (2009)
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
Brian V. Balgobind et al.
BLOOD (2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
I. H. I. M. Hollink et al.
LEUKEMIA (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group
John T. Horan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy
Nancy J. Bunin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia
L. Charles Bailey et al.
LANCET ONCOLOGY (2008)
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
James B. Nachman et al.
BLOOD (2007)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen et al.
LANCET (2007)
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study
Henrik Hasle et al.
BLOOD (2007)
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia
Paul A. Carpenter et al.
BLOOD (2007)
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi et al.
BLOOD (2006)
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9
Anne R. M. von Bergh et al.
GENES CHROMOSOMES & CANCER (2006)
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as patients conditioning regimens for undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission
DI Marks et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy:: Results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Miinster Group 87
HG Einsiedel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse
E Coustan-Smith et al.
LEUKEMIA (2004)
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy?
P Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
G Michel et al.
BLOOD (2003)
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia:: prognostic significance and relation to cellular drug resistance
CM Zwaan et al.
BLOOD (2003)
Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia:: A Pediatric Blood and Marrow Transplant Consortium study
N Bunin et al.
BONE MARROW TRANSPLANTATION (2003)
Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome:: results of NOPHO-AML trials
SO Lie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis
A Borgmann et al.
BLOOD (2003)
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
S Meshinchi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors
F Locatelli et al.
LEUKEMIA (2002)
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome
M Zecca et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
C Eckert et al.
LANCET (2001)
No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission
UM Saarinen-Pihkala et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
V Rocha et al.
BLOOD (2001)
Biological and therapeutic aspects of infant leukemia
A Biondi et al.
BLOOD (2000)
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia
SM Davies et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
